Latest Ratios: P/E Ratio -0.1x · EV/EBITDA N/A · ROE -76.3%. (2016–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $202035 | $1M | $2M | $2M | $5M | $14M | $12M | $18M | $3M | $12M | $20M |
| Enterprise Value | $-1440865 | $-294544 | $2M | $2M | $5M | $14M | $12M | $18M | $4M | $12M | $16M |
| P/E Ratio → | -0.08 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 0.07 | 0.47 | 0.82 | 0.50 | 1.17 | 2.93 | 2.35 | 3.24 | 16.69 | 2.94 | 33.97 |
| P/B Ratio | 0.05 | 0.19 | 0.55 | 0.49 | 0.70 | 2.12 | 2.13 | 2.60 | — | 1.52 | 1.47 |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | -0.10 | 0.80 | 0.50 | 1.15 | 3.00 | 2.33 | 3.15 | 26.00 | 2.93 | 26.99 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.0% | 32.0% | 25.0% | 33.4% | 35.0% | 39.9% | 32.6% | 21.0% | -1841.7% | 36.2% | 35.0% |
| Operating Margin | -33.3% | -33.3% | -42.1% | -38.1% | -52.6% | -82.3% | -116.0% | -214.4% | -2387.4% | -267.3% | -830.5% |
| Net Profit Margin | -154.4% | -154.4% | -38.0% | -104.6% | -45.7% | -82.3% | -142.0% | -206.9% | -9722.4% | -284.0% | -703.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -76.3% | -76.3% | -27.2% | -74.9% | -28.0% | -62.8% | -116.9% | -571.4% | -558.4% | -109.7% | -30.3% |
| ROA | -62.4% | -62.4% | -18.0% | -51.3% | -20.1% | -38.6% | -71.8% | -146.7% | -189.3% | -100.9% | -29.7% |
| ROIC | -14.5% | -14.5% | -22.8% | -20.7% | -23.7% | -46.1% | -74.9% | -361.3% | -81.7% | -95.7% | -38.4% |
| ROCE | -16.4% | -16.4% | -29.8% | -26.7% | -30.9% | -59.3% | -93.3% | -592.2% | -136.5% | -103.1% | -35.8% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.07 | 0.05 | 0.00 | — | 0.04 | 0.04 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.23 | -0.01 | -0.00 | -0.02 | 0.06 | -0.01 | -0.07 | — | -0.01 | -0.30 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -0.49 | -0.49 | -9.90 | -616.42 | -584.55 | — | — | -475.92 | -13.63 | — | — |
Net cash position: cash ($2M) exceeds total debt ($1539)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.72 | 2.72 | 0.27 | 0.19 | 0.38 | 0.33 | 0.47 | 0.42 | 0.66 | 0.40 | 16.96 |
| Quick Ratio | 2.72 | 2.72 | 0.27 | 0.19 | 0.38 | 0.26 | 0.26 | 0.42 | 0.03 | 0.40 | 16.96 |
| Cash Ratio | 2.21 | 2.21 | 0.06 | 0.04 | 0.11 | 0.03 | 0.08 | 0.16 | 0.00 | 0.22 | 16.45 |
| Asset Turnover | — | 0.36 | 0.47 | 0.61 | 0.44 | 0.51 | 0.49 | 0.56 | 0.03 | 0.43 | 0.04 |
| Inventory Turnover | — | — | — | — | — | 17.77 | 3.52 | — | 0.54 | — | — |
| Days Sales Outstanding | — | 39.75 | 45.50 | 29.24 | 30.37 | 36.63 | 50.56 | 52.58 | 78.26 | 30.07 | 5.21 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | 8.0% | — | 0.0% |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 8.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $485020 | $97246 | $68844 | $53191 | $46704 | $40254 | $27839 | $3616 | $2498 | $1291 |
Capital exhaustion and insolvency
As reported in recent financial filings, the company's gross margin has fluctuated wildly between 17.5% and 50.2% over the last ten quarters, suggesting that the business lacks a stable, high-margin core and remains heavily dependent on the unpredictable nature of its transactional revenue streams.
The persistent negative operating margins, which reached -56.3% in 2024Q4, indicate that the company has failed to achieve the necessary scale to cover its fixed cost base. Investors should monitor whether the recent improvement in gross margin to 50.2% in 2026Q1 represents a sustainable shift toward software-led revenue or merely a temporary fluctuation in product mix.
Based on quarterly data, the company's Days Sales Outstanding (DSO) has remained elevated, peaking at 68 days in 2025Q3, which suggests that the firm struggles to collect payments efficiently from its hospital clients, further exacerbating the cash burn inherent in its current operating model.
The lack of consistent data for Days Payable Outstanding and the Cash Conversion Cycle makes it difficult to assess the company's leverage over suppliers. However, the high DSO relative to the company's small revenue base implies that working capital management is a significant drag on the firm's limited cash reserves.
According to the most recent balance sheet, the current ratio improved to 2.53 in 2026Q1, yet this metric appears misleading as it masks the company's inability to generate positive operating cash flow, leaving the firm vulnerable to sudden liquidity shocks if external financing becomes unavailable.
While the current ratio suggests a temporary buffer, the company's reliance on non-cash adjustments and the absence of positive free cash flow indicate that this liquidity is likely fleeting. The firm's dependence on its existing cash balance to fund ongoing operations warrants extreme caution regarding its long-term viability.
Investors frequently misapply the Price-to-Sales (P/S) ratio to evaluate this business, which obscures the fact that the company's revenue is derived from disparate, low-quality sources rather than a unified, high-margin software platform, rendering traditional valuation benchmarks largely irrelevant for assessing its true intrinsic value.
Using a P/S multiple fails to account for the massive gap between operating and net margins, which suggests that the company's revenue is not translating into shareholder value. A more appropriate metric would be a cash-burn-adjusted valuation or a focus on the unit economics of the core healthcare data normalization segment, excluding the volatile ticketing and PPE components.
Includes 30+ ratios · 10 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying WORX stock.
SCWorx Corp.'s current P/E ratio is -0.1x. This places it at the 50th percentile of its historical range.
SCWorx Corp.'s return on equity (ROE) is -76.3%. The historical average is -65.8%.
Based on historical data, SCWorx Corp. is trading at a P/E of -0.1x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
SCWorx Corp. has 32.0% gross margin and -33.3% operating margin.